The Preferred Drug List and other drug lists for 2009 are now available and can be reviewed in the Pharmacy section of bcbst.com.
Changes to the PDL for 2009
The following drugs will cost members LESS. They will move from Tier 3 (highest copay) to Tier 2 (lower copay):
The following drugs will cost members more. They are moving from Tier 2 (lower copay) to Tier 3 (highest copay). Preferred brands may be available for these drugs, and generic equivalents are indicated in bold.
*Members taking Cozaar and Hyzaar will receive a letter later in the year to alert them to this change and encourage them to save money by trying one of the generic or preferred alternatives.
Changes to the Quantity Limitations List
The Preferred Drug List (PDL) is reviewed annually to determine needed changes based on drugs’ clinical effectiveness, safety and affordability. This review includes an analysis to determine a long-term “Lowest Net Cost” for members and groups.
While many changes to the PDL occur at the beginning of the year, drugs on the PDL can change throughout the year due to market changes such as
© 2008 BlueCross BlueShield of Tennessee,
Inc., an Independent Licensee of the BlueCross BlueShield Association.